MedTrace Logo

Study on CRP Apheresis After Coronary Bypass Surgery

NCT04745468 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2022-10-18

No results posted yet for this study

Summary

The CABY1 study is conducted open, controlled, randomized and monocentric. The efficacy and tolerability of CRP apheresis in patients undergoing elective primary coronary bypass surgery is investigated.

Conditions

  • Post-cardiac Surgery

Interventions

DEVICE

CRP apheresis

Selective CRP apheresis by use of the PentraSorb-CRP adsorber

Sponsors & Collaborators

  • Pentracor GmbH

    lead INDUSTRY

Principal Investigators

  • Matthias Thielmann, Prof. Dr. med. · Westdeutsches Herz- und Gefäßzentrum Essen, Klinik für Thorax- und Kardiovaskuläre Chirurgie

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-21
Primary Completion
2021-01-28
Completion
2021-01-28

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745468 on ClinicalTrials.gov